Ex-Purdue exec's new immunology startup launches with $60M
May 06, 2020 at 07:00 AM EDT
The biotech plans to create drugs that target the immune system’s first line of defense, known as the innate immune system.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|